We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$83B
AUM Growth
+$4.08B
(+5.2%)
Cap. Flow
-$2.07B
Cap. Flow
% of AUM
-2.5%
Top 10 Holdings %
Top 10 Hldgs %
13.18%
Holding
730
New
59
Increased
161
Reduced
398
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$550M |
| 2 |
Fidelity National Information Services
FIS
|
+$353M |
| 3 |
Global Payments
GPN
|
+$263M |
| 4 |
CVS Health
CVS
|
+$175M |
| 5 |
Devon Energy
DVN
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$433M |
| 2 |
Lowe's Companies
LOW
|
+$277M |
| 3 |
Oracle
ORCL
|
+$226M |
| 4 |
Progressive
PGR
|
+$220M |
| 5 |
Las Vegas Sands
LVS
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.96% |
| 2 | Healthcare | 15.3% |
| 3 | Industrials | 15.12% |
| 4 | Technology | 14.91% |
| 5 | Consumer Discretionary | 11.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Booz Allen Hamilton
BAH
$8.59B
| $6.92M | 0.01% |
81,615
-754
| -0.9% | -$63.6K |
|
377
iShares Russell 2000 Value ETF
IWN
$14.4B
| $6.6M | 0.01% |
39,767
+21,455
| +117% | +$3.58M |
|
378
Viatris
VTRS
$20.5B
| $6.58M | 0.01% |
486,685
-100,941
| -17% | -$1.35M |
|
379
CBIZ
CBZ
$2.39B
| $5.98M | 0.01% |
152,945
-1,717
| -1% | -$64K |
|
380
Apple
AAPL
$4.95T
| $5.86M | 0.01% |
33,018
+200
| +0.6% | +$31.6K |
|
381
Broadcom
AVGO
$1.82T
| $5.68M | 0.01% |
85,440
-8,600
| -9% | -$483K |
|
382
V2X
VVX
$2.73B
| $5.63M | 0.01% |
123,046
-4,882
| -4% | -$231K |
|
383
Merchants Bancorp
MBIN
$2.22B
| $5.14M | 0.01% |
163,016
-1,867
| -1% | -$56K |
|
384
Velocity Financial
VEL
$692M
| $5.08M | 0.01% |
370,841
-3,302
| -0.9% | -$42.6K |
|
385
FerroAtlántica
GSM
$617M
| $5.08M | 0.01% |
+817,837
| New | +$5.59M |
|
386
Americold
COLD
$4.17B
| $4.83M | 0.01% |
147,180
-3,296
| -2% | -$102K |
|
387
ScottsMiracle-Gro
SMG
$4.06B
| $4.79M | 0.01% |
+29,726
| New | +$4.6M |
|
|
DHIL
388
DELISTED
Diamond Hill
DHIL
| $4.74M | 0.01% |
24,379
-157
| -0.6% | -$31.4K |
|
|
LHCG
389
DELISTED
LHC Group LLC
LHCG
| $4.36M | 0.01% |
31,741
-353
| -1% | -$48.2K |
|
390
Abbott
ABT
$182B
| $4.33M | 0.01% |
30,762
-7,169
| -19% | -$918K |
|
391
Moody's
MCO
$84.2B
| $4.26M | 0.01% |
10,914
-371
| -3% | -$143K |
|
392
Perella Weinberg Partners
PWP
$1.18B
| $4.14M | 0.01% |
322,242
-3,463
| -1% | -$45.6K |
|
393
RBB Bancorp
RBB
$451M
| $4.03M | ﹤0.01% |
153,986
-1,689
| -1% | -$43.2K |
|
394
Procter & Gamble
PG
$346B
| $3.9M | ﹤0.01% |
23,858
-1,568
| -6% | -$233K |
|
395
Regions Financial
RF
$26.2B
| $3.9M | ﹤0.01% |
178,851
-13,324
| -7% | -$305K |
|
396
Newmark Group
NMRK
$2.82B
| $3.89M | ﹤0.01% |
208,108
| – | – |
|
397
AllianceBernstein
AB
$3.54B
| $3.73M | ﹤0.01% |
76,311
| – | – |
|
398
First Internet Bancorp
INBK
$231M
| $3.71M | ﹤0.01% |
78,942
-867
| -1% | -$35.1K |
|
399
HP
HPQ
$24.3B
| $3.56M | ﹤0.01% |
94,469
-9,765
| -9% | -$319K |
|
|
HSII
400
DELISTED
Heidrick & Struggles
HSII
| $3.55M | ﹤0.01% |
81,245
-17,115
| -17% | -$779K |
|
Similar funds
Boston Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Boston Partners held 730 positions worth $83B, up 5.2% from $78.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Boston Partners's Q4 2021 filing shows 59 new, 161 increased, 398 reduced and 45 closed positions. Its largest new stake was Keurig Dr Pepper: 15,605,496 shares worth $575M. The largest sale was Pfizer, an estimated $433M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q4 2021 buy was Keurig Dr Pepper: 15,605,496 shares worth $575M.
- Boston Partners added most to Fidelity National Information Services in Q4 2021, an estimated $353M increase.
- Boston Partners's biggest Q4 2021 reduction was Pfizer, cutting an estimated $433M.
- Boston Partners fully exited CyrusOne Inc Common Stock in Q4 2021, selling an estimated $137M.
- Boston Partners's ten largest holdings make up 13% of its $83B portfolio in Q4 2021.
- Boston Partners opened 59 new positions and closed 45 in Q4 2021.
- Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $83B.
Based on Boston Partners's 13F filing for Q4 2021, filed 4 Feb 2022.